1325. How Can We Prevent Cardiovascular Disease in our HIV-Infected Patients?
Session: Symposium: Inflammation and End Organ Disease: From the Bench to the Bedside
Saturday, October 10, 2015: 9:30 AM
Room: 28--ABCDE
Steven Grinspoon, MD, Program in Nutritional Metabolism, Massachusetts General Hospital, Boston, MA

Resume/CVs:


Disclosures:

S. Grinspoon, Navidea: Consultant , Consulting fee
Theratechnologies: Consultant , Consulting fee
KOWA: Grant Investigator , Research grant
Gilead: Grant Investigator , Research grant
Amgen: Grant Investigator , Research grant
Theratechnologies: Grant Investigator , Research grant
Novo Nordisk: Consultant , Consulting fee

<< Previous Presentation | Next Presentation

Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 7th with the exception of research findings presented at the IDWeek press conferences.